The analysis of the relationships between circulating FGF19, BA synthesis, cholestasis and prognosis presented in this report further an understanding of PBC pathophysiology and support the therapeutic potential of blocking hepatic BA synthesis. This evidence concerns the gene FGF19 and primary biliary cholangitis.